BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12176471)

  • 1. Alternative immunosuppression for acute renal failure in liver transplantation: role of ultra-low dose tacrolimus and basiliximab.
    Varo E; Lopez A; Castroagudin JF; Delgado M; Conde R; Ferrer E; Otero E; Tomé S; Bustamante M; Rivero C; Martinez J; Mariño A
    Transplant Proc; 2002 Aug; 34(5):1533-4. PubMed ID: 12176471
    [No Abstract]   [Full Text] [Related]  

  • 2. The renal-sparing efficacy of basiliximab in adult living donor liver transplantation.
    Lin CC; Chuang FR; Lee CH; Wang CC; Chen YS; Liu YW; Jawan B; Chen CL
    Liver Transpl; 2005 Oct; 11(10):1258-64. PubMed ID: 16184544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric renal transplantation under tacrolimus or cyclosporine immunosuppression and basiliximab induction.
    Garcia CD; Schneider L; Barros VR; Guimarães PC; Garcia VD
    Transplant Proc; 2002 Nov; 34(7):2533-4. PubMed ID: 12431513
    [No Abstract]   [Full Text] [Related]  

  • 4. Basiliximab reduces acute liver allograft rejection in pediatric patients.
    Strassburg A; Pfister ED; Arning A; Nashan B; Ehrich JH; Melter M
    Transplant Proc; 2002 Sep; 34(6):2374-5. PubMed ID: 12270443
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction with basiliximab reduces acute rejection in pediatric liver transplant patients treated with tacrolimus and steroids.
    Asensio M; Margarit C; Chavez R; Ortega J; Charco R; Iglesias J
    Transplant Proc; 2002 Aug; 34(5):1970-1. PubMed ID: 12176650
    [No Abstract]   [Full Text] [Related]  

  • 6. Experience with the use of basiliximab in liver transplantation--use in pediatric and adult recipients in combination with cyclosporine or tacrolimus.
    Petz W; Spada M; Bertani A; Lucianctti A; Casagrande F; Guizzetti M; Corno V; Colledan M; Strazzabosco M; Gridelli B
    Transplant Proc; 2002 Aug; 34(5):1966-7. PubMed ID: 12176648
    [No Abstract]   [Full Text] [Related]  

  • 7. Initial immunosuppression with or without basiliximab: a comparative study.
    Martín-Mateos RM; Graus J; Albillos A; Arocena C; Rodríguez Gandía MA; Blesa C; García-Hoz F; García González M; García-Alonso FJ; Bárcena R
    Transplant Proc; 2012 Nov; 44(9):2570-2. PubMed ID: 23146457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of basiliximab induction in low-immunological risk renal transplant recipients receiving tacrolimus-based immunosuppression.
    Gavela Martínez E; Avila Bernabeu AI; Sancho Calabuig A; Beltrán Catalán S; Escudero Quesada V; Pallardó Mateu LM
    Transplant Proc; 2009; 41(6):2337-8. PubMed ID: 19715913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid-free liver transplantation in children.
    Reding R; Gras J; Sokal E; Otte JB; Davies HF
    Lancet; 2003 Dec; 362(9401):2068-70. PubMed ID: 14697809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A safe immunosuppressive protocol in adult-to-adult living related liver transplantation.
    Gruttadauria S; Cintorino D; Piazza T; Mandala L; Doffria E; Musumeci A; Di Trapani G; Arcadipane A; Scianna G; Spada M; Verzaro R; Volpes R; Vizzini G; Palazzo U; Minervini M; Marsh JW; Marcos A; Gridelli B
    Transplant Proc; 2006 May; 38(4):1106-8. PubMed ID: 16757278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basiliximab in the therapy of acute rejection after organ transplantation.
    Chariat MN; Erren M; Chariat M; Deng M; Wolters HH; Dietl KH
    Transplant Proc; 2001 May; 33(3):2380. PubMed ID: 11377567
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative study of the cellular pharmacodynamics of tacrolimus in renal transplant recipients treated with and without basiliximab.
    Sugiyama K; Isogai K; Horisawa S; Toyama A; Satoh H; Saito K; Nakagawa Y; Tasaki M; Takahashi K; Hirano T
    Cell Transplant; 2012; 21(2-3):565-70. PubMed ID: 22793066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid-free, tacrolimus-basiliximab immunosuppression in pediatric liver transplantation: clinical and pharmacoeconomic study in 50 children.
    Gras JM; Gerkens S; Beguin C; Janssen M; Smets F; Otte JB; Sokal E; Reding R
    Liver Transpl; 2008 Apr; 14(4):469-77. PubMed ID: 18383091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basiliximab in a triple-drug regimen with tacrolimus and steroids in liver transplantation.
    Gruttadauria S; Vasta F; Mandalà L; Cintorino D; Piazza T; Spada M; Verzaro R; Gridelli B
    Transplant Proc; 2005; 37(6):2611-3. PubMed ID: 16182762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus-Basiliximab versus Cyclosporine-Basiliximab in renal transplantation "de novo": acute rejection and complications.
    Martin Garcia D; Martin Gago J; Mendiluce A; Gordillo R; Bustamente J
    Transplant Proc; 2003 Aug; 35(5):1694-6. PubMed ID: 12962761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation, Acute Renal Failure, and Complications of Basiliximab Use After Liver Transplantation: Analysis of 114 Patients and Literature Review.
    de Ataide EC; Perales SR; Bortoto JB; Peres MAO; Filho FC; Stucchi RSB; Udo E; Boin IFSF
    Transplant Proc; 2017 May; 49(4):852-857. PubMed ID: 28457410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of basiliximab with a tacrolimus-based regimen in liver transplant recipients.
    Marino IR; Doria C; Scott VL; Foglieni CS; Lauro A; Piazza T; Cintorino D; Gruttadauria S
    Transplantation; 2004 Sep; 78(6):886-91. PubMed ID: 15385809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients.
    Calmus Y; Scheele JR; Gonzalez-Pinto I; Jaurrieta EJ; Klar E; Pageaux GP; Scudamore CH; Cuervas-Mons V; Metselaar HJ; Prestele H; Girault D
    Liver Transpl; 2002 Feb; 8(2):123-31. PubMed ID: 11862588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with basiliximab in pediatric liver graft recipients.
    Ganschow R; Lyons M; Grabhorn E; Venzke A; Broering DC; Rogiers X; Hellwege HH; Burdelski M
    Transplant Proc; 2001; 33(7-8):3606-7. PubMed ID: 11750532
    [No Abstract]   [Full Text] [Related]  

  • 20. Basiliximab decreases the incidence of acute rejection after intestinal transplantation.
    Sudan DL; Chinnakotla S; Horslen S; Iyer K; Fox I; Shaw B; Langnas AN
    Transplant Proc; 2002 May; 34(3):940-1. PubMed ID: 12034250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.